Back to search
FDAFDA · Food and drugs·Recall number D-0569-2018

DADIYONGSHI XIANGGANGTIANLONGSHENGWU tablets, 6-count bottle, labeling is in foreign language

Published February 7, 2018 · Recall initiated: March 7, 2017

Summary

FDA records drug Class I recall D-0569-2018, published February 7, 2018 and initiated March 7, 2017. Recalling firm: A&H Focal Inc.; Status: Terminated; Reported quantity: unknown; Lot: All Lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
A&H Focal Inc.
Distributor
NY and NJ through six retail stores named "Asian Food Markets"
Lot
All Lots
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DADIYONGSHI XIANGGANGTIANLONGSHENGWU tablets, 6-count bottle, labeling is in foreign language recalled?

Yes. FDA published recall D-0569-2018 on February 7, 2018. Reported hazard: Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release